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EBV Infection as a Cause of VT:
Evaluation by CMR
Myocarditis represents an important cause of unexpected
sudden death. Approximately half of all fatal cases are due to
Coxsackie B, and most of the remainder to Coxsackie A,
echovirus, and poliovirus. There are few reports about fatal
cases due to Epstein-Barr virus (EBV) (1).
We evaluated with cardiac magnetic resonance (CMR) and
endomyocardial biopsy (EMB) 6 patients age 35 to 68 years (2
women/4 men) without history of systemic disease or immu-
nosuppressive treatment who presented with ventricular tachy-
cardia (VT) and negative coronary angiogram. In 4 of 6
patients, the clinical presentation was compatible with acute
myocarditis. Their symptoms included lymphadenopathy; fe-
ver; chest pain; VT and ST elevation equal to 1 mm in II, III,
aVF; increase in creatine kinase MB fraction and troponin I
(creatine kinase-MB fraction was 77, 92, 87, and 105 ng/ml
[normal values 3.6 ng/ml] and troponin I was 8.2, 12.2,
13.5, and 15.2 ng/ml [normal values 0.10 ng/ml], respec-
tively). One of 4 experienced a sudden death episode and was
successfully resuscitated. The other 2 with a past history of
EBV infection 2 years ago (confirmed by positive serology for
EBV IgM antibodies during the acute infection), completely
asymptomatic until admission, presented with VT and sudden
death, and one of them was successfully resuscitated.
CMR was performed within 2 to 5 days after the VT.
T2-weighted, early gadolinium enhanced (EGE), and late
gadolinium enhanced (LGE) injection images were evaluated.
The patient was considered positive for myocarditis if at least
2 of 3 imaging sequences gave positive results (2). Left
ventricular function was assessed by steady-state free-
precession sequence. Images were evaluated by 2 independent
readers, and the kappa value was 0.83.
Table 1. Clinical, ECG, Laboratory, and CMR Findings of Patients Posi
Patient # Symptoms ECG
C
(n
1 Chest pain, fever ST-segment elevation II, III, aVF;
ventricular tachycardia
2 Chest pain, fever ST-segment elevation II, III, aVF;
ventricular tachycardia
3 Chest pain, fever ST-segment elevation II, III, aVF;
ventricular tachycardia
4 Chest pain, fever ST-segment elevation II, III, aVF;
ventricular tachycardia
5 Arrhythmia Ventricular tachycardia
6 Arrhythmia Ventricular tachycardia
Normal values: creatine kinase (CK)-MB fraction, 3.6 ng/ml; troponin I (Tn I), 0.10 ng
0%; left ventricular end-diastolic volume (LVEDV), 136 30 ml (77 to 195 ml), left ventri
(LVEF), 67  5% (56% to 78%) (4).
CMR  cardiac magnetic resonance; ECG  electrocardiogram.The EMB was performed in all of the patients because of
cute myocarditis with VT in 4 of 6 and the possibility of
ealed myocarditis (owing to past history with EBV) or any
ther myocardial disease presented with VT in the other 2 of
. Eight endomyocardial specimens were obtained from the
ight side of the ventricular septum of each patient (4 used for
istologic evaluation and 4 for deoxyribonucleic acid/
ibonucleic acid extraction to detect viral genomes). The
etection of 14 infiltrating leukocytes/mm2 with myocyte
amage and/or fibrosis was used for the diagnosis of active
yocarditis. Healing myocarditis was considered if the inflam-
ation was less extensive (14 leukocytes/mm2), whereas
healed myocarditis was characterized by multifocal fibrosis or
scarring without inflammation (0 to 3 leukocytes/mm2, which
s identical to normal myocardium). Polymerase chain reaction
PCR) was performed for viral detection (coxsackieviruses,
choviruses, adenoviruses, parvovirus B19, human cytomega-
ovirus, EBV, and Herpes viruses 1 to 6) (3).
CMR was positive for acute myocarditis in all patients with
cute symptoms. However, in the 2 patients who presented
ith VT and past history of EBV, only LGE lesions in the
osterior wall were identified. The left ventricular ejection
raction was reduced in 2 of 4 with acute symptoms and in 1
f 2 with past history of EBV (Table 1) (4). Histology revealed
he presence of active myocarditis in all 4 patients with acute
yocarditis and healed myocarditis in those with a past history
f EBV infection. Myocardial PCR identified EBV in all
atients. A patient with positive LGE area and active myo-
arditis is presented in Figure 1.
In this study, we identified VT episodes in 6 patients with
current or past history of EBV infection. The clinical diagnosis
was verified by both CMR and EMB, and the presence of
EBV was documented by myocardial PCR. T2 and EGE
images were positive only in the patients with acute myocar-
ditis, and they were compatible with the histologic findings
indicative of acute myocarditis. In contrast, in the 2 patients
for Myocarditis
B
l)
Tn I
(ng/ml) T2 EGE
LGE
(%)
LVEDV
(ml)
LVESV
(ml)
LVEF
(%)
8.2 2.2 18.20 4 108 45 58
12.2 2.3 8.30 6 130 68 48
13.5 2.7 10.65 8 140 54 61
15.2 2.1 13.60 10 105 60 43
N 1.1 3.22 5 128 65 49
N 1.5 2.25 8 120 42 65
2, 2; early gadolinium enhancement (EGE), 4; late gadolinium enhancement (LGE),
end-systolic volume (LVESV), 45  14 ml (19 to 72 ml), left ventricular ejection fractiontive
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Letters to the Editor562with a past history of EBV, CMR detected only fibrotic lesions, and
the histology documented healed myocarditis, emphasizing the
complementary role of the 2 techniques in myocarditis assessment.
EBV infection usually presents neurologically or hematologi-
cally, with no cardiac complications. Although it can lead to
myocarditis in immunodepressed patients, it has been rarely attrib-
uted to myocarditis in immunocompetent patients. Myocardial viral
genome evaluation in dilated cardiomyopathy showed a high
prevalence of viruses in the myocardium (Parvo-B19 51.4%; Herpes
virus 6 21.6%). However, the EBV genome was found in only 2%
of patients (1).
The interesting finding in our patients was that the typical signs
and symptoms of EBV infection occurred simultaneously with
cardiac symptoms. Fatal myocarditis has already been described as
a rare complication during acute EBV infection, but not in healed
myocarditis after EBV infection. According to our findings,
EBV can provoke VT by both acute and chronic myocardial
inflammation.
This study has some limitations because: 1) only a small number
of patients were examined; 2) children and patients with immuno-
deficiency and/or under immunosuppressive treatment prone to
EBV infection were not included; and 3) only a short-term
follow-up was performed.
In conclusion, a common virus like EBV, usually known for
extracardiac complications, can provoke VT both on an acute and a
chronic basis. There is a complementary association between EMB
and CMR in myocarditis evaluation.
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Regional Differences in
Aortic Geometry
Pathologic or Compensatory?
We refer to the Hickson et al. (1) recent interesting report on
regional differences in aortic stiffness. As they note, their results are
in contrast to 3 other reports in the literature (2,3), including our
own (4), raising themes that warrant further discussion. First,
Hickson et al. (1) make a very important point, specifically, that
aortic diameter is an important, but usually overlooked, influence
on pulse wave velocity. This is particularly relevant since pulse wave
velocity, despite being a surrogate marker, has become the nonin-
vasive gold standard for assessment of arterial stiffness. Second, our
study used cardiac magnetic resonance to calculate the local
distensibility directly, not the pulse wave velocity, and found the
predominant effect of aging was an increase in the difference
between the distensibility of the ascending compared with that of
the distal aorta.
Both our own and Hickson et al.’s (1) report show that ageing
appears to have its predominant absolute effect in the distal
descending aorta, although in our cohorts, the greatest proportional
change occurred in the proximal (elastic) aorta. Hickson et al. (1)
are probably correct in that changes in aortic diameter tend to
compensate for primary distensibility changes, and this may be
responsible for their variant results.
In this context, a serious dilemma remains as to whether
ea in the Inferior Wall and Matching Pathology Image
(left, arrow) and corresponding pathology image (right, arrows), indicative ofE Ar
cledistensibility (and possibly diameter changes per se) or the deranged
